Delivery Order SPE2DR25D7066-SPE2DR26F7ZEW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,540.02 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML on August 12, 2025, with completion scheduled for August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Timolol 0.5% Gel-Solution 5ML, with a ceiling value of $3,427.07. This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a ceiling value of $1,217.05. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,800.72 to AmerisourceBergen Drug Corp for Timolol 0.25% gel-solution in 5ml quantities. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by October 29, 2025, just one day after the award date of October 28, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,514.00 to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Timolol 0.25% Gel-Solution 5ML. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical supply requirements. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 17, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a contract ceiling value of $6,814.03. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $11,953.10 to AmerisourceBergen Drug Corp for Timolol 0.5% gel-solution in 5ml units. This non-competitive, firm fixed-price delivery order was issued on June 18, 2025, with an ultimate completion date of June 20, 2025. The contract will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker medication primarily used for glaucoma treatment and post-operative eye care,...
- The Defense Logistics Agency awarded a delivery order valued at $10,886.71 to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML on September 18, 2025, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker medication commonly used to treat glaucoma and ocular...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Timolol 0.5% eye drops in 5ml quantities, with a ceiling value of $1,420.89. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is due for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Timolol is a beta-blocker...
- The Defense Logistics Agency awarded a delivery order valued at $1,818.40 to AmerisourceBergen Drug Corp for the supply of Timolol 0.5% Gel-Solution 5mL, a topical ophthalmic medication commonly used to treat glaucoma and ocular hypertension. This firm fixed-price delivery order, issued on August 8, 2025, was competitively awarded with no set-aside designation and carries an ultimate completion date of August 11, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania,...
- SPE2DR25D7066Indefinite Delivery Contract
- SPE2DR25D7066-SPE2DR26F7ZEWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Timolol 0.5% Gel-Solution 5ML with a ceiling value of $2,884.19. This competitively awarded, non-set-aside delivery order was issued on November 18, 2025, with an ultimate completion date of November 19, 2025. The contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 pharmaceutical prime vendor agreement running through December 2026. As a critical pharmaceutical distributor supporting military and federal healthcare systems, AmerisourceBergen maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains. The Timolol order represents routine pharmaceutical procurement to support Defense Health Agency medical supply chain requirements and reflects the company's consistent role in fulfilling federal medication needs through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 11/18/25 |